NCT00793520

Effect of Milnacipran on Pain Processing and Functional Magnetic Resonance Imaging (fMRI) Activation Patterns in Patients With Fibromyalgia

• Status: Terminated
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 2 (actual)
• Sponsor: Forest Laboratories · Industry
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate the effect of milnacipran on how the brain processes pain in patients with fibromyalgia and to assess the relationship between this effect and brain activation patterns during functional magnetic resonance imaging.

Conditions

• Fibromyalgia

Interventions

Type	Name	Description
DRUG	Milnacipran	Twice daily oral administration of Milnacipran for 5 weeks.
DRUG	Placebo	Twice daily oral administration of placebo for 5 weeks.
DRUG	Placebo	Twice daily oral administration of placebo for 5 weeks.
DRUG	Milnacipran	Twice daily oral administration of Milnacipran for 5 weeks.

Timeline

• Start date: 2008-11-01
• Primary completion: 2009-04-01
• First posted: 2008-11-19
• Last updated: 2010-07-01
• Results posted: 2010-07-01

Locations

1 site across 1 country: United States